Literature DB >> 16320304

PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy.

Martine M Mirrione1, Wynne K Schiffer, Mustafa Siddiq, Stephen L Dewey, Stella E Tsirka.   

Abstract

Here we present the first demonstration that 2-deoxy-2[18F]fluoro-D-glucose (18FDG) and micro Positron Emission Tomography (microPET) can be used successfully to monitor regional changes in brain metabolism during acute seizure induction in C57Bl/6 mice. These longitudinal studies show a significant increase in 18FDG uptake in the hippocampus (33.2%) which correlates directly with seizure severity (R2=0.86). 18FDG microPET can potentially be used to monitor the development of TLE in mouse models from the acute phase of status epilepticus to the chronic phase of spontaneous recurrent seizures. These studies provide a foundation upon which we can begin to identify genetic contributions to the metabolic signature of TLE in mice, since many transgenics are in the C57Bl/6 background strain. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16320304     DOI: 10.1002/syn.20216

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

1.  Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.

Authors:  Jun-Rong Zhu; Hai-Dan Lu; Chao Guo; Wei-Rong Fang; Hong-Dong Zhao; Jun-Shan Zhou; Feng Wang; Yan-Li Zhao; Yun-Man Li; Ying-Dong Zhang; Chang-Qing Yang; Jian-Guo Sun
Journal:  Acta Pharmacol Sin       Date:  2018-11       Impact factor: 6.150

2.  Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

Authors:  Martine M Mirrione; Dorothy K Konomos; Iordanis Gravanis; Stephen L Dewey; Adriano Aguzzi; Frank L Heppner; Stella E Tsirka
Journal:  Neurobiol Dis       Date:  2010-04-09       Impact factor: 5.996

3.  Tissue plasminogen activator alters intracellular sequestration of zinc through interaction with the transporter ZIP4.

Authors:  Jaime Emmetsberger; Martine M Mirrione; Chun Zhou; Monica Fernandez-Monreal; Mustafa M Siddiq; Kyungmin Ji; Stella E Tsirka
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

Review 4.  Epilepsy and epileptic syndrome.

Authors:  Tomonori Ono; Aristea S Galanopoulou
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography.

Authors:  Rahul A Sheth; Lee Josephson; Umar Mahmood
Journal:  J Biomed Opt       Date:  2009 Nov-Dec       Impact factor: 3.170

6.  A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator.

Authors:  Martine M Mirrione; Wynne K Schiffer; Joanna S Fowler; Dave L Alexoff; Stephen L Dewey; Stella E Tsirka
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

7.  Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.

Authors:  Minsook Ye; Hwan-Suck Chung; Yong Ho An; Su-Jin Lim; Won Choi; A Ram Yu; Jin Su Kim; Manho Kang; Seunghun Cho; Insop Shim; Hyunsu Bae
Journal:  Mol Neurobiol       Date:  2015-10-07       Impact factor: 5.590

8.  Workshop on Neurobiology of Epilepsy appraisal: new systemic imaging technologies to study the brain in experimental models of epilepsy.

Authors:  Stefanie Dedeurwaerdere; Sandy R Shultz; Paolo Federico; Jerome Engel
Journal:  Epilepsia       Date:  2014-05-16       Impact factor: 5.864

9.  Neuroimaging in Animal Seizure Models with (18)FDG-PET.

Authors:  Martine M Mirrione; Stella E Tsirka
Journal:  Epilepsy Res Treat       Date:  2011-07-07

10.  The neuroprotective effect of gugijihwang-tang on trimethyltin-induced memory dysfunction in the rat.

Authors:  Eun-Yee Jung; Mi-Sook Lee; Chang Joon Ahn; Seung-Hun Cho; Hyunsu Bae; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.